If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by libaiyi – China, 2021-02-02 09:39 (97 d 22:25 ago) – Posting: # 22199
Views: 709

Dear all,

Recently I meet a problem about sample size of high variance drug, normally, we will design a repeated cross-over trial for this kind of drug. But this time it is designed as a parallel study due to some reasons. But the sample size is too much based on 80%-125% BE CI. So my quesion is if we have any method to widen the CI like RSABE in cross-over study? Thank you very mcuh.:-D

Sincerely,
libaiyi

Complete thread:

Activity
 Admin contact
21,446 posts in 4,483 threads, 1,511 registered users;
online 16 (0 registered, 16 guests [including 12 identified bots]).
Forum time: Tuesday 09:05 CEST (Europe/Vienna)

The fact that some geniuses were laughed at
does not imply that all who are laughed at are geniuses.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5